Transfusion strategies in women during Major Obstetric Haemorrhage

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON28409

Enrollment

1600

Registered

2013-07-17

Start date

2013-04-22

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Obstetric Haemorrhage

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Transfusion of FFP and/or platelets alongside RBC transfusion AND Obstetric haemorrhage in pregnancy (including early pregnancy), during the first 24 hours following delivery or in puerperium (limited to 6 weeks after delivery).

Exclusion criteria

Exclusion criteria: Timing of transfusion of blood components not recorded or not obtainable.

Design outcomes

Primary

Measure	Time frame
Maternal mortality and severe maternal morbidity. Severe maternal morbidity will be defined as a postpartum hysterectomy, postpartum arterial embolisation and/or intensive care unit admission.	—

Contacts

Public ContactHenriquez

Center for Clinical Transfusion Research (Sanquin Research) Plesmanlaan 1A

D.D.C.A.Henriquez@lumc.nl071-5685126

Outcome results